News archive for Centre for Cancer Biomarkers CCBIO

What happens when tumors get nervous? (20.12.2024)

12 mill NOK was today (Dec. 20, 2024) awarded to Lars A. Akslen and Heidrun Vethe from the Research Council of Norway (FRIPRO) on the project "When breast cancer hits a nerve - neural involvement as a hallmark of tumor progression."

Picture from the auditorium with many people in the audience, and the speaker being introduced on the stage.

Inspirational last CCBIO seminar of 2024 (19.12.2024)

CCBIO has a tradition of using the December meeting in its seminar series to add a different perspective and encourage our research environment to think outside of the box. This December, we had the pleasure of welcoming back Fran Balkwill, who has a unique experience in addition to her cancer research career.

Brekken as speaker on a CCBIO conference.

New biomarker identified for therapeutic intervention for reducing tumor progression (19.12.2024)

The result of years of collaboration between CCBIO PI Jim Lorens and Rolf Brekken and other colleagues in the USA, Finland, Romania and Norway, is now published in Science Signaling, with research identifying nuclear AKT3 as a new biomarker of advanced malignancy and revealing the pathway that activates AKT3 to drive epithelial-to-mesenchymal transition in pancreatic cancer.

Course in methods of cancer biomarker research (19.12.2024)

CCBIO recently held its signature course Methods in Cancer Biomarker Research (CCBIO905), September 25-27, 2024, at Haukeland University Hospital, providing the attending students with a full panel of standard and advanced methods with relevance for cancer biomarker research.

Collage of Tessa in Boston, standing in front of Harvard Medical School, working in the lab with a microscope, being in the library, and seeing Boston skyline.

3-month visit in Boston (19.12.2024)

This year, one of CCBIO's students got the opportunity to have a 3-month research stay in Boston, due to CCBIO's INTPART collaboration with Harvard Medical School and Boston Children's Hospital. PhD Candidate Tessa Lohr reports of a great experience, highly recommending it to other young researchers.

The Trond Mohn Research Foundation supports ovarian cancer project (03.12.2024)

CCBIO's Co-Director Line Bjørge receives support for her group's project "Rethinking Ovarian Cancer: Developing Diagnostic and Functional Tools and Designing Innovative Multimodal Treatment Strategies."

Collage of situation photos from the meeting.

2nd CCBIO-VBP Research Meeting, 2024 (02.12.2024)

This meeting at Solstrand August 28–31, 2024 was the 2nd Research Meeting in the INTPART collaboration between CCBIO and the Vascular Biology Program (VBP), Boston Children’s Hospital and Harvard Medical School, the first being the Iceland meeting in 2019. In 2019, 48 participants met in Iceland, and this year, 57 gathered at Solstrand.